1. Home
  2. FPAY vs RVPH Comparison

FPAY vs RVPH Comparison

Compare FPAY & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • RVPH
  • Stock Information
  • Founded
  • FPAY 2003
  • RVPH 2006
  • Country
  • FPAY United States
  • RVPH United States
  • Employees
  • FPAY N/A
  • RVPH N/A
  • Industry
  • FPAY Diversified Commercial Services
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • FPAY Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • FPAY 27.2M
  • RVPH 26.6M
  • IPO Year
  • FPAY N/A
  • RVPH N/A
  • Fundamental
  • Price
  • FPAY $1.04
  • RVPH $0.46
  • Analyst Decision
  • FPAY Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • FPAY 2
  • RVPH 5
  • Target Price
  • FPAY $3.25
  • RVPH $9.00
  • AVG Volume (30 Days)
  • FPAY 96.0K
  • RVPH 3.2M
  • Earning Date
  • FPAY 08-05-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • FPAY N/A
  • RVPH N/A
  • EPS Growth
  • FPAY N/A
  • RVPH N/A
  • EPS
  • FPAY N/A
  • RVPH N/A
  • Revenue
  • FPAY $139,800,732.00
  • RVPH N/A
  • Revenue This Year
  • FPAY $16.58
  • RVPH N/A
  • Revenue Next Year
  • FPAY N/A
  • RVPH N/A
  • P/E Ratio
  • FPAY N/A
  • RVPH N/A
  • Revenue Growth
  • FPAY 19.51
  • RVPH N/A
  • 52 Week Low
  • FPAY $0.84
  • RVPH $0.30
  • 52 Week High
  • FPAY $2.37
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 36.61
  • RVPH 46.82
  • Support Level
  • FPAY $0.84
  • RVPH $0.44
  • Resistance Level
  • FPAY $1.37
  • RVPH $0.53
  • Average True Range (ATR)
  • FPAY 0.10
  • RVPH 0.04
  • MACD
  • FPAY -0.00
  • RVPH 0.02
  • Stochastic Oscillator
  • FPAY 9.30
  • RVPH 56.07

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: